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Dietary habits may diﬀer between Parkinson’s disease (PD) patients of diﬀerent ethnicities. 'e primary aim of this cross-sectional
analysis was to compare dietary habits in a multiethnic PD population and investigate potential nonmotor diﬀerences. All patients
completed a dietary habits questionnaire. Besides basic demographics, patients’ motor involvement (Hoehn and Yahr (HY)) and
nonmotor symptoms (Nonmotor Symptoms Scale; Hospital Anxiety and Depression Scale) were assessed. 139 PD patients were
included (mean age 66.8± 11.6 years; 61.2%male;mean disease duration 6.2± 5.2 years;medianHY 3): 47.5%wereWhite, 24.5%Asian,
and 28.0% Black African and Caribbean (BAC). We found dietary diﬀerences between the groups, including a greater frequency of
vegetarians and greater consumption of cumin, turmeric, and cinnamon as well as lower consumption of beef in Asian patients than in
White andBAC and greater consumption of chili than inWhite patients and higher consumption of pork inWhite thanAsian andBAC
patients. 'ere were no signiﬁcant diﬀerences in dietary supplement consumption after correction for multiple comparisons. None of
the dietary factors examined were associated with diﬀerences in nonmotor symptoms. Diet and supplement use vary in PD patients
across ethnicities, this is both a problem and opportunity for nutritional medicine research. 'ese data support the importance of
considering ethnic diversity as part of recruitment strategy in nutrition and clinical studies.
1. Introduction
Parkinson’s disease (PD) is a heterogeneous disorder, with
considerable phenotypic variability, which may be inﬂuenced
by genetic, epigenetic, and environmental factors [1]. Amongst
the environmental factors, it has been suggested that diet might
play a role in PD [2, 3]. For example, it has been reported that
patients with PD are less likely than controls to adhere to
a Mediterranean diet, consume green tea, coﬀee, blueberries,
avoid dairy products or have higher serum vitamin B6, D, and
E levels. Lower adherence to this diet was associated with
younger age of onset [3–6]. In addition, higher urate plasma
levels in men have been associated with lower risk of PD in
a prospective case-control study [7]. Previously, work has also
hypothesised that vegan and vegetarian diet might have
a beneﬁcial eﬀect on PD [3, 8]. However, to date there is not
suﬃcient evidence to recommend any speciﬁc dietary modi-
ﬁcations to inﬂuence rate and progression of PD [9].
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Dietary habits may diﬀer between PD patients of dif-
ferent ethnicities; however, data as to whether this may
inﬂuence the phenotypic expression of PD are lacking. 'is
study is part of a large multiethnic cohort study of nonmotor
aspects of PD and the role of ethnicity (“Nonmotor
symptoms of Parkinson’s in multi-racial ethnic groups,”
United Kingdom clinical research network number 18278).
We primarily aimed to compare the dietary habits of
a multiethnic PD population using a patient-completed diet
questionnaire and address possible links between the dif-
ferent dietary habits and the clinical expression of nonmotor
symptoms in patients with PD.
We examined the following concepts:
(1) Do dietary patterns diﬀer between PD patients of
Black African and Caribbean and Asian groups of
either ﬁrst or second generation resident in the
United Kingdom compared to White PD patients
[10]?
(2) Is dietary supplement use diﬀerent between the
White and the non-White PD groups? Speciﬁcally,
we would look at intake of vitamin D, turmeric,
coﬀee, and black tea as these have been associated
with possible eﬀects on the natural history of PD [2].
(3) Is there a separate pattern of phenotypic expression
with a focus of nonmotor symptoms of PD with the
use of dietary supplements?
2. Materials and Methods
2.1. Study Design and Study Sites. 'is was a cross-sectional
analysis, and data were collected as part of an ongoing
multicentre, prospective, observational real-life study called
“Nonmotor symptoms of Parkinson’s in multi-racial ethnic
groups.” 'is is an National Institute for Health Research
(NIHR) portfolio-adopted study (United Kingdom clinical
research network number 18278). Four diﬀerent sites in South
and North London, United Kingdom, were included (King’s
College Hospital, Lewisham Hospital, Luton and Dunstable
Hospital, and Queen Elizabeth Hospital). 'ese areas had
preexisting multiethnic PD cohort databases.
2.2. Ethical Approval. 'e study was carried out in accor-
dance with the Declaration of Helsinki and authorised by the
local ethics committees. All patients gave written consent
prior to taking part in the study procedures.
2.3. Patients. All included patients had a conﬁrmed diagnosis
of PD as per the United Kingdom Brain Bank criteria [11] and
attended the Movement Disorders Clinics in London, United
Kingdom, at one of the included sites. In this analysis, we
included all patients who had completed a diet questionnaire
which was designed for this study andwas based on the toolkit
developed by Mischley and colleagues [3].
2.4. Clinical Assessment. Ethnicity was assessed using the
criteria from the Oﬃce for National Statistics from the
Census 2011 in England and Wales. Besides demographics
including age, disease duration, levodopa equivalent daily
dose [12], and body mass index (body weight/height2), the
following clinical assessments were performed:
(1) Dietary habits: 'e patient completed the “diet
questionnaire,” a modiﬁed version of the food fre-
quency questionnaire (FFQ) used in the “Comple-
mentary and alternative medicine in PD (CAM Care
in PD) study.”'e questionnaire was adapted for the
purpose of this study and was simpliﬁed and
modiﬁed based on our experience of patient reports
and a literature review of factors relevant to PD. 'e
questionnaire was completed as follows: First, par-
ticipants were asked if they followed any speciﬁc diet
in the last 6 months with 12 options (no dietary
restrictions, calorie restricted, ketogenic, paleo, low
carbohydrate, low fat, low protein, vegan, vegetarian,
low salt, low sugar, and other diet). Secondly, par-
ticipants were asked to tick the box if they had taken
any vitamins, supplements, or spices/herbs during
the last month. As a next step, participants were
asked to give the frequency of the average intake of
several foods over the last 6 months. 'ese foods
included meat (chicken, beef, pork, and ﬁsh), fresh
red and nonred vegetables, fresh fruits, cheese, milk,
diet and nondiet soft-ﬁzzy drinks, and breads, pasta,
grains, soy, and nuts. 'e questions could be an-
swered by ticking one of the 12 diﬀerent options
ranging from “never” to “4–6 times daily.”
(2) Motor assessment included the Hoehn and Yahr
(HY) scale [13]. 'e scale classiﬁes the severity of
Parkinsonian symptoms into 5 broad stages and
allows disease progression and deterioration to be
measured [14]: Stage 1 (unilateral involvement);
Stage 2 (bilateral without balance impairment); Stage
3 (bilateral with balance impairment, but physically
independent); Stage 4 (unable to walk assisted); and
Stage 5 (conﬁned to bed or wheelchair).
(3) Nonmotor assessment included the comprehensive
nonmotor symptoms scale (NMSS) covering nine dif-
ferent nonmotor symptoms domains (cardiovascular,
sleep/fatigue, mood/apathy, perception/hallucinations,
attention/memory, gastrointestinal, urinary, sexual,
and miscellaneous) [15]. Furthermore, patients
completed the Hospital Anxiety and Depression
Scale (HADS), a patient-completed scale including
14 diﬀerent items (7 for depression and 7 for
anxiety) [16].
2.5. Statistics. Data were stored anonymously in a data-
base and analysed using the Statistical Package for Social
Sciences (version 23.0 for Mac; SPSS). Demographics were
presented as mean and standard deviation, median and
interquartile range and percentage for each variable as ap-
propriate. Normality of distribution was assessed with the
Kolmogorov–Smirnov test. As all variables were not nor-
mally distributed, nonparametric tests were applied. To
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investigate if there were statistical diﬀerences in categorical
variables between the three diﬀerent ethnic groups (White,
Asian, and Black African and Caribbean) Pearson’s chi-
square test or Fisher’s exact test was applied. Further-
more, to calculate if there were statistical diﬀerences in
continuous not normally distributed variables between the
three diﬀerent ethnic groups (White, Asian, and Black
African and Caribbean) the Kruskal–Wallis test was applied.
Post hoc analysis was conducted between the diﬀerent pairs
of ethnicities (Asian versus White, Asian versus Black Af-
rican and Caribbean, and White versus Black African and
Caribbean).
For the analysis comparing consumption of a speciﬁc
dietary item, we divided the groups in “consumption” and
“negligible consumption” which was deﬁned as consump-
tion of the dietary item once a month or less than once
a month. 'ese were arbitrary cutoﬀs. 'e Mann–Whitney
U test between two groups was applied to investigate dif-
ferences between these groups.
A p value <0.05 was considered to be statistically sig-
niﬁcant. If applicable, the Bonferroni correction was used to
account for multiple comparisons.
3. Results
One hundred thirty-nine patients who completed the diet
questionnaire were considered for this speciﬁc analysis.
Among those, 66 (47.5%) wereWhite, 34 (24.5%) Asian, and
39 (28.0%) Black African and Caribbean. Basic character-
istics are summarized in Table 1.'e three ethnic groups did
not signiﬁcantly diﬀer regarding age, gender, HY, or body
mass index. 'ere were diﬀerences in disease duration
(Asian mean 7.8 ± 7.3 years, Black African and Caribbean
mean 4.6 ± 4.2 years, and White population mean 6.3 ± 4.2
years) as well as levodopa equivalent daily doses (mean 763.5± 520.7, 536.7 ± 453.4, and 737.5 ± 631.5, respectively).
3.1. Types of Diet. 'e number and frequencies of patients
who followed any speciﬁc diets (White, Asian, and Black
African and Caribbean) are shown in Table 2. We found
a statistically signiﬁcant diﬀerence in proportions for pa-
tients who followed calorie-restricted, paleo, low-fat, vege-
tarian, and low-sugar diet (all p< 0.05). After correction for
multiple comparisons, these diﬀerences remained statisti-
cally signiﬁcant only for the vegetarian diet.
Post hoc analysis between the diﬀerent pairs of eth-
nicities with a Bonferroni correction showed that Asians
followed signiﬁcantly more frequent a vegetarian diet
compared to both groups, White and Black African and
Caribbean (26.5% versus 4.5% and 2.6%, respectively)
(Table 2).
3.2. Use of Supplements between the ;ree Diﬀerent Ethnic
Groups. 'e use of supplements is summarized in Table 3
according to each ethnicity. Statistically signiﬁcant diﬀer-
ences were observed in relation to reported intake of vitamin
D. However, this diﬀerence did not remain statistically
signiﬁcant after correction for multiple comparisons.
3.3. Dietary Habits including Herbs and Beverages Such as
Coﬀee, Black, and Green Tea. We found statistically signif-
icant diﬀerences between the three groups in the con-
sumption of fresh chili, fresh herbs, cumin, turmeric,
cinnamon, and green tea. After correction for multiple
comparisons, all diﬀerences remained statistically signiﬁcant
except for fresh herbs and green tea.
Post hoc analysis between the diﬀerent pairs of eth-
nicities with a Bonferroni correction showed that Asian PD
patients consumed signiﬁcantly more frequently cumin
(73.5% versus 16.7% and 20.5%), turmeric (70.6% versus
16.7% and 20.5%), and cinnamon (64.7% versus 16.7% and
35.9%) compared to the White and Black African and
Caribbean population. Furthermore, the Asian population
reported signiﬁcantly more chili consumption compared to
the White which was not signiﬁcantly diﬀerent to the Black
African and Caribbean PD population (Table 4).
3.4. Other Dietary Habits between the ;ree Diﬀerent Ethnic
Groups. We found statistically signiﬁcant diﬀerences be-
tween the three groups in the consumption of beef, pork,
ﬁsh, cheese, grains, and nuts. After correction for multiple
comparisons, only the diﬀerences for beef and pork
remained statistically signiﬁcant. Post hoc analysis revealed
that White and Black African and Caribbean consumed
signiﬁcantly more beef compared to Asian patients (56.1%
versus 48.7% versus 12.1%, respectively), while White
consumed signiﬁcantly more pork compared to the other
two ethnic groups (57.6% versus 23.7% versus 9.1%, re-
spectively) (Table 5).
3.5.ClinicalParametersand theEﬀectof SpeciﬁcDietary Items.
In an exploratory analysis, we compared the nonmotor
features in those who reported to follow any speciﬁc diet (as
listed in Table 2) and consumed speciﬁc nutritional sup-
plements (shown in Table 3) and herbs and beverages such as
coﬀee, black, and green tea (shown in Table 4) (irrespective
of ethnic background) to those who did not, using the NMSS
total score, the nine diﬀerent NMSS domains, and the HADS
total score. Due to the limited sample size, we did not
compare the eﬀect of diﬀerent dietary intakes such as
consumption of chicken or beef as shown in Table 5.
After correction for multiple comparisons, we did not
ﬁnd any statistically signiﬁcant diﬀerences in clinical pa-
rameters between the groups who consumed any of the
dietary items outlined above.
4. Discussion
Dietary inﬂuences have been proposed as possible modu-
lators for clinical aspects of PD related to ethnicity. To our
knowledge, this is one of the ﬁrst studies to explore the
relationship between ethnicity and diet in PD. In spite of
a relatively small sample size, we believe that this study
provides some interesting observations. Firstly, we examined
the dietary proﬁle in patients with PD which may be of
relevance to clinical features and conﬁrmed diﬀerences in
dietary factors between the three diﬀerent ethnic groups
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studied (White, Asian, and Black African and Caribbean). As
all patients studied in this paper were residents in the United
Kingdom, they were exposed to a similar choice of food
types. Whilst our ﬁndings suggest that the majority of pa-
tients with PD in each ethnic group followed no dietary
restrictions, there were dietary diﬀerences between the
multiethnic PD groups: Asian patients with PD, similar to
what has been reported in non-PD populations [17],
signiﬁcantly more frequent followed a vegetarian diet and
consumed cumin, turmeric, and cinnamon than White or
Black African and Caribbean patients. Both Asian and Black
African and Caribbean patients consumed less pork than
White patients, and Asian patients consumed less beef and
more fresh chili than White or Black African and Caribbean
patients. Unadjusted comparison also suggested higher
green tea consumption in Black African and Caribbean
Table 4: Dietary habits including herbs and beverages such as coﬀee, black, and green tea between the three diﬀerent ethnic groups.
White (N � 66) Asian (N � 34) BAC (N � 39)
p value
N % N % N %
Fresh chili/fresh chili powder 21 31.8 24 70.6 21 53.8 0.001∗,A
Fresh herbs 26 39.4 22 64.7 16 41.0 0.042
Cumin 11 16.7 25 73.5 8 20.5 <0.001∗,A,B
Turmeric 11 16.7 24 70.6 8 20.5 <0.001∗,A,B
Oregano 14 21.2 9 26.5 6 15.4 0.506
Cayenne 6 9.1 9 26.5 8 20.5 0.063
Cinnamon 11 16.7 22 64.7 14 35.9 <0.001∗,A,B
Green tea 8 12.1 8 23.5 15 38.5 0.007
Black tea 31 47.0 14 41.2 16 41.0 0.784
Coﬀee 43 65.2 16 47.1 20 51.3 0.159
Abbreviations: N � number, BAC � Black African and Caribbean. Fisher’s exact test was used to test diﬀerences between the three diﬀerent ethnic groups.∗'ese remain statistically signiﬁcant after adjustment for multiple comparisons (p � 0.005). Post hoc analysis between the diﬀerent pairs of ethnicities:
multiple comparisons were corrected with the Bonferroni method; signiﬁcant diﬀerences are highlighted as A for Asian versus White and B for Asian versus
Black African and Caribbean.
Table 2: Dietary habits including speciﬁc diets between the three diﬀerent ethnic groups.
White (N � 66) Asian (N � 34) BAC (N � 39)
p value
N % N % N %
No dietary restriction 50 75.8 20 58.8 23 59.0 0.108
Calorie restricted 4 6.1 0 0 6 15.4 0.034
Ketogenic 0 0 1 2.9 0 0 0.245
Paleo 1 1.5 0 0 5 12.8 0.014
Low carbohydrate 1 1.5 1 2.9 2 5.1 0.689
Low fat 5 7.6 2 5.9 10 25.6 0.018
Low protein 0 0 0 0 1 2.6 0.525
Vegan 0 0 1 2.9 1 2.6 0.274
Vegetarian 3 4.5 9 26.5 1 2.6 0.001∗,A,B
Low salt 4 6.1 3 8.8 8 20.5 0.072
Low sugar 6 9.1 4 11.8 11 28.2 0.025
Other diets 4 6.1 4 11.8 1 2.6 0.318
Abbreviations: N � number; BAC � Black African and Caribbean. Fisher’s exact test was used to test diﬀerences between the three diﬀerent ethnic groups.∗'ese remain statistically signiﬁcant after adjustment for multiple comparisons (p � 0.0042). Post hoc analysis between the diﬀerent pairs of ethnicities:
multiple comparisons were corrected with the Bonferroni method; signiﬁcant diﬀerences are highlighted as A for Asian versus White and B for Asian versus
Black African and Caribbean.
Table 3: Dietary habits including supplements between the three diﬀerent ethnic groups.
White (N � 66) Asian (N � 34) BAC (N � 39)
p value
N % N % N %
Vitamin C 10 15.2 6 17.6 4 10.3 0.649
Vitamin D 12 18.2 14 41.2 9 23.1 0.040
Vitamin B6 1 1.5 3 8.8 3 7.7 0.142
Vitamin B12 4 6.1 5 14.7 4 10.3 0.362
Folic acid 1 1.5 1 2.9 4 10.3 0.100
Betaine 0 0 0 0 1 2.6 0.525
Abbreviations: N � number; BAC � Black African and Caribbean. Fisher’s exact test was used to test diﬀerences between the three diﬀerent ethnic groups.∗None remain statistically signiﬁcant after correction for multiple comparisons (p � 0.008).
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Table 5: Other dietary habits between the three diﬀerent ethnic groups.
White Asian BAC
p value
N % N % N %
Chicken (serving size: 1 large or two small pieces (125 grams))
Weekly Consumption 58 87.9 23 69.7 32 82.1 0.086Negligible consumption 8 12.1 10 30.3 7 17.9
Beef (serving size: 1 large or two small pieces (125 grams))
Weekly consumption 37 56.1 4 12.1 19 48.7 <0.001∗,A,BNegligible consumption 29 43.9 29 87.9 20 51.3
Pork (serving size: 1 large or two small pieces (125 grams))
Weekly consumption 38 57.6 3 9.1 9 23.7 <0.001∗,A,CNegligible consumption 28 42.4 30 90.9 29 76.3
Fish (serving size: 1 large or two small pieces (125 grams))
Weekly consumption 55 83.3 22 66.7 35 89.7 0.037Negligible consumption 11 16.7 11 33.3 4 10.3
Red vegetables (serving size: 1/2 cup)
Weekly consumption 61 92.4 32 94.1 33 86.8 0.578Negligible consumption 5 7.6 2 5.9 5 13.2
Nonred vegetables (serving size: 1/2 cup)
Weekly consumption 63 95.5 31 93.9 36 92.3 0.894Negligible consumption 3 4.5 2 6.1 3 7.7
Fresh fruits (serving size: 1 medium)
Weekly consumption 65 98.5 31 93.9 38 97.4 0.360Negligible consumption 1 1.5 2 6.1 1 2.6
Cheese (serving size: 1 slice, 15 grams)
Weekly consumption 57 86.4 23 67.6 25 64.1 0.017Negligible consumption 9 13.6 11 32.4 14 35.9
Milk (serving size: 1 cup (do not include nondairy milks))
Weekly consumption 54 81.8 27 79.4 34 89.5 0.468Negligible consumption 12 18.2 7 20.6 4 10.5
Diet soft-ﬁzzy drinks (serving size: 1 can)
Weekly consumption 24 36.4 11 32.4 11 28.2 0.688Negligible consumption 42 63.6 23 67.6 28 71.8
Nondiet soft-ﬁzzy drinks (serving size: 1 can)
Weekly consumption 18 27.3 12 35.3 9 23.1 0.501Negligible consumption 48 72.7 22 64.7 30 76.9
Bread (serving size: 1 slice or 1 roll)
Weekly consumption 63 96.9 32 94.1 37 94.9 0.656Negligible consumption 2 3.1 2 5.9 2 5.1
Pasta (serving size: 1 cup)
Weekly consumption 47 73.4 17 50.0 23 59.0 0.057Negligible consumption 17 26.6 17 50.0 16 41.0
Grains (serving size: 1 cup)
Weekly consumption 54 84.4 33 97.1 39 100.0 0.006Negligible consumption 10 15.6 1 2.9 0 0.0
Soy (serving size: 1 cup)
Weekly consumption 5 7.6 6 17.6 3 7.7 0.290Negligible consumption 61 92.4 28 82.4 36 92.3
Nuts (serving size: one serving 1/3 cups)
Weekly consumption 40 60.6 23 67.6 15 37.5 0.026Negligible consumption 26 39.4 11 32.4 24 61.5
Abbreviations: N � number; BAC � Black African and Caribbean. Pearson’s chi-square test or Fisher’s exact test was used to test diﬀerences between the three
diﬀerent ethnic groups. ∗'ese remain statistically signiﬁcant after adjustment for multiple comparisons (p � 0.003). Post hoc analysis between the diﬀerent pairs
of ethnicities: multiple comparisons were corrected with Bonferroni method; signiﬁcant diﬀerences are highlighted as A for Asian versusWhite, B for Asian versus
Black African and Caribbean, and C for White versus Black African and Caribbean.
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patients than in Asian or White patients, but this diﬀerence
was no longer signiﬁcant after adjustment for multiple
comparisons. Similar diﬀerences in diet have been reported
in the overall population of Asian and Black African and
Caribbean in the United Kingdom [17].
Secondly, we examined nonmotor features between
patients who reported speciﬁc diet intake such as vegetarian
and intake of speciﬁc nutritional supplements and con-
sumption of herbs and beverages such as coﬀee, black, and
green tea (irrespective of ethnic background) and those who
did not. 'is is relevant to address personalized diet, an
aspect of the circle of personalized medicine as recently
described [18]. We did not ﬁnd any clinical diﬀerences in PD
symptoms in relation to these dietary factors. However,
given the small number of participants and the number of
individuals reporting utilization of speciﬁc diets and sup-
plements and herbs, these results should be considered
exploratory. In speciﬁc cohorts, there is some evidence that
some dietary aspects may inﬂuence the pattern of Parkin-
sonism. For instance, in Guadelope, the prolonged intake of
fruits of Annonacea has been associated with a high per-
centage of atypical and nondopamine responsive Parkin-
sonisms [19]. 'e Annonacea plant contains isoquinolinic
alkaloids and acetogenins, which are neurotoxins, and both
are mitochondrial complex I inhibitors resulting
in Parkinsonism-type disorders [20]. Similarly, in Guam,
the ALS-PDC (amyotrophic lateral sclerosis/parkinsonism-
dementia complex) has been largely related to intake of
cycad toxin seeds [21]. Cycads contain neurotoxic amino
acids β-D-glucoside (cycasin) and β-N-methylamino-L-ala-
nine (BMAA), which are consumed by the Chamorro people
in traditional foods, medicines, fruit bat [22, 23].
'ere have also been reports that dietary intake may
inﬂuence the rate of manifest established PD: examples
include high intakes of fruits, vegetables, whole grains, le-
gumes, poultry, and ﬁsh [5]. Further examples are studies
reporting an eﬀect of curcumin on PD. Curcumin, derived
from turmeric, acts as an anti-inﬂammatory and antioxidant
polyphenol. Research by Liu et al. andWang et al. established
an eﬀect of curcumin on alpha-synuclein-induced cell death,
and thioﬂavins and polyphenols found in fermented black tea
also have antioxidising properties [24, 25]. Initial work by
Grelle et al. found that, on a cellular level, theaﬂavins act by
preventing and reversing amyloid formation [26]. In addition,
it has been suggested that higher urate concentration in the
blood could modify the risk of developing PD as well as the
progression rate in particular in men [7, 27]. Furthermore,
mainly case reports have suggested that vegan and vegetarian
diet might be beneﬁcial in PD [8, 28].'e possible underlying
mechanism has been suggested to be an improved levodopa
absorption and modiﬁcation of the loss of surviving dopa-
minergic neurons in the brain [8, 28].
'e existence and mechanism of a possible relationship
between dietary intake and progression rate of phenotype
are unclear, but a link has been postulated [7]. A recent
review by Erro et al. alluded on the possible patho-
mechanisms between nutrition and neurodegeneration in-
cluding aspects such as altered levels of proinﬂammatory
mediators, microglia activation, and inﬂammation [9]. In
addition, the relationship between neurodegeneration and
intestinal microbiota is receiving increasingly attention,
which is directly related to dietary habits and PD [29].
'is study has several limitations. Firstly, we applied
a patient-completed questionnaire, and this may have led to
underreporting as patients might underestimate, for instance,
the consumption of dairy products [30]. Secondly, the amount
of the consumed dietary items was not quantiﬁed. Supplement
intake was recorded as a binary variable, and we did not assess
doses or measure blood vitamin levels in this observational
study of self-reported intake. Subtle or dose related diﬀerence
could therefore not be assessed. 'e sample size in this study
was also comparatively low, and we were therefore not able to
conduct statistical analysis on the eﬀect of dietary habits on the
clinical expression of PD in speciﬁc ethnic groups. However,
the results could form the basis of larger prospective
population-based studies to further address the questions if
there is a possible eﬀect of diet on the clinical symptoms
expressionin PD and if this diﬀers between ethnic groups.
5. Conclusions
To our knowledge, this is one of the ﬁrst reports on dietary
habits in diﬀerent ethnic populations living in the United
Kingdom aﬀected with PD. Our data suggest that dietary
habits diﬀer between diﬀerent ethnic groups aﬀected with
PD. 'ere is conﬂicting evidence in relation to the impact of
diet on PD including the rate of manifest PD, progression
rate, and clinical symptoms expression. 'e identiﬁcation of
strong evidence of the link between diet and PD could have
important consequences for the prevention and treatment of
this heterogeneous condition. Our results highlight that
there are diﬀerences in dietary habits between patients with
PD from diﬀerent ethnic groups, and larger, more detailed
studies investigating the eﬀect of dietary habits on the
clinical expression of motor and nonmotor symptoms are
warranted.
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